Endoscopic Sinus Surgery (ESS): This is a standard of care surgical procedure performed according to clinical routine. No experimental treatment or investigational drug is administered as part of this study.
Study summary
This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Participant must be 16 years of age or older, at the time of signing the informed consent.
2. Participants with a documented diagnosis of CRSwNP.
3. Endoscopic nasal polypectomy is performed during the screening period.
4. Voluntarily participate and sign the informed consent form as described in A 3.
5. No history or current psychiatric disorders, with normal cognitive functions including understanding, expression, and orientation.
Exclusion Criteria:
1. Any significant disease or disorder that the investigator believes may place the patient at risk or may affect the study results or the patient's ability to participate in the study.
2. Currently participating in an interventional study.
3. Patients who are unable to independently complete questionnaires due to language barriers or mental status.
Primary outcome measure(s)
• The observed and change from baseline of Sino-Nasal Outcome Test (SNOT)-22 score at week-52 — week0-52 Assess the Change in Sinonasal outcome test-22(SNOT-22) at 52 weeks post-operatively \[SNOT-22: score 0-5 each item, 5 means worse outcome, 22 items totally\]
• The observed and change from baseline of Modified Lund-Kennedy (MLK) score at week-52 — week0-52 Assess the opacification of the paranasal sinuses by using Modified Lund-Kennedy (MLK) score at week 52.
\[MLK score: score 0-24, 24 means worse outcome\]
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.